These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

8303 related articles for article (PubMed ID: 1571095)

  • 81. Role of intermediate filaments in migration, invasion and metastasis.
    Hendrix MJ; Seftor EA; Chu YW; Trevor KT; Seftor RE
    Cancer Metastasis Rev; 1996 Dec; 15(4):507-25. PubMed ID: 9034607
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Survival rate of young patients with malignant choroidal melanoma after conservative treatment].
    Romanowska B; Zygulska-Mach H; Ksiezyk M
    Klin Oczna; 1998; 100(4):211-6. PubMed ID: 9770979
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Karyometrical and cytochemical studies of Harding-Passey melanoma and Horning-Mitchely kidney tumour. 3. Cytochemistry of some hydrolytic enzymes.
    el-Fiky SM; Fahmy TY; Abdo SE
    Acta Histochem; 1971; 41(1):102-7. PubMed ID: 5004555
    [No Abstract]   [Full Text] [Related]  

  • 84. Induction of antitumor effect by treatment with cyclosporine A plus interferon-gamma after chemotherapy: role of cytotoxic cells.
    Charak BS; Brown EG; Mazumder A
    J Immunother Emphasis Tumor Immunol; 1995 Apr; 17(3):131-40. PubMed ID: 7613640
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Factors regulating growth and pigmentation of melanoma cells.
    Pawelek JM
    J Invest Dermatol; 1976 Apr; 66(4):201-9. PubMed ID: 178804
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Relation between immunogenicity and differentiation of metastasis in an experimental murine melanoma].
    Heinen E; Beckers J; Desaive C; Lennes G; Simar L
    C R Seances Soc Biol Fil; 1982; 176(2):223-6. PubMed ID: 6212110
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Melanocytic nevi in Turner syndrome.
    Becker B; Jospe N; Goldsmith LA
    Pediatr Dermatol; 1994 Jun; 11(2):120-4. PubMed ID: 8041650
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Diagnosis and differential diagnosis of malignant melanomas of the choroid.
    De Laey JJ
    Bull Soc Belge Ophtalmol; 1993; 248():6-10. PubMed ID: 8044333
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Transcriptional suppression of HLA-B expression by c-Myc is mediated through the core promoter elements.
    Peltenburg LT; Schrier PI
    Immunogenetics; 1994; 40(1):54-61. PubMed ID: 8206526
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Enhanced anti-tumor effect of an IFN-gamma-EGF fusion protein.
    Chen WQ; Ding YP; Zhang LL; Hou YD
    Biomed Environ Sci; 1997 Dec; 10(4):387-95. PubMed ID: 9448920
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Biological and biochemical activities of the novel antitumor antibiotic PD 114,759 and related derivatives.
    Fry DW; Shillis JL; Leopold WR
    Invest New Drugs; 1986; 4(1):3-10. PubMed ID: 3754542
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Expression of the human hematopoietic progenitor cell antigen CD34 in vascular and spindle cell tumors.
    Cohen PR; Rapini RP; Farhood AI
    J Cutan Pathol; 1993 Feb; 20(1):15-20. PubMed ID: 7682226
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Antineoplastic properties of pyrimidinone interferon inducers.
    Stringfellow DA
    Adv Enzyme Regul; 1980; 19():335-48. PubMed ID: 6175189
    [No Abstract]   [Full Text] [Related]  

  • 94. Cell cycle regulation by environmental pH.
    Taylor IW; Hodson PJ
    J Cell Physiol; 1984 Dec; 121(3):517-25. PubMed ID: 6501429
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Cancer-associated mis-sense and deletion mutations impair p16INK4 CDK inhibitory activity.
    Lilischkis R; Sarcevic B; Kennedy C; Warlters A; Sutherland RL
    Int J Cancer; 1996 Apr; 66(2):249-54. PubMed ID: 8603820
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Control of growth and vascularity of B16 melanoma by syngeneic lymphocytes.
    Gersten DM
    Cell Biol Int Rep; 1980 Apr; 4(4):407-14. PubMed ID: 6156016
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Magnetic resonance imaging: an emerging technique for the diagnosis of ocular disorders.
    Smith EV; Gragoudas ES; Kolodny NH; D'Amico DJ
    Int Ophthalmol; 1990 Mar; 14(2):119-24. PubMed ID: 2159952
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [Synergistic effect of targeted inhibition of MEK/ERK and PI3K/AKT survival signaling pathways on induction of apoptosis in melanoma].
    Wang XY; Cheng Y; Du JP; Chen DG; Yang XS; Yang ZM; Huang N
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 May; 45(3):355-61. PubMed ID: 24941796
    [TBL] [Abstract][Full Text] [Related]  

  • 99. A randomised phase II study of carmustine alone or in combination with tumour necrosis factor in patients with advanced melanoma.
    Jones AL; O'Brien ME; Lorentzos A; Viner C; Hanrahan A; Moore J; Millar JL; Gore ME
    Cancer Chemother Pharmacol; 1992; 30(1):73-6. PubMed ID: 1586984
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The new anthracycline 4-demethoxydaunorubicin by oral route in advanced pretreated breast cancer and melanoma. A pilot study.
    Martoni A; Pacciarini MA; Pannuti F
    Drugs Exp Clin Res; 1985; 11(2):127-31. PubMed ID: 3915281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 416.